![](/img/cover-not-exists.png)
Phase I and II Study of the Safety, Virologic Effect, and Pharmacokinetics/Pharmacodynamics of Single-Dose 3-O-(3',3'-Dimethylsuccinyl)Betulinic Acid (Bevirimat) against Human Immunodeficiency Virus Infection
Smith, P. F., Ogundele, A., Forrest, A., Wilton, J., Salzwedel, K., Doto, J., Allaway, G. P., Martin, D. E.Volume:
51
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/aac.00152-07
Date:
October, 2007
File:
PDF, 160 KB
english, 2007